General Notices

• Notice of Special Topics of Interest for CDER for PAR-23-072 "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)"
  (NOT-FD-23-007)
  Food and Drug Administration
  

• Notice of Technical Assistance Webinar for RFA-HL-24-003 & RFA-HL-24-004 "Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24) & (R25 Clinical Trial Not Allowed)"
  (NOT-HL-23-075)
  National Heart, Lung, and Blood Institute
  

Notice of Changes to Funding Opportunities

• Notice of Change to Key Dates to RFA-AG-24-003, Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-AG-23-003)
  National Institute on Aging
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
  (NOT-MD-23-002)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
  (NOT-MD-23-003)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Eye Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS)
  (NOT-NS-23-062)
  National Institute of Neurological Disorders and Stroke
  

Funding Opportunities

• Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  (PAR-23-035)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): March 21, 2023